May 26, 2022 -- Excelra is partnering with HotSpot Therapeutics to further the discovery and development of small molecule therapy candidates directed toward allosteric targets that have been difficult to treat, or untreatable, with traditional small molecule approaches.
HotSpot Therapeutics will use data from Excelra's flagship product Global Online Structure Activity Relationship (GOSTAR) database with its machine learning and artificial intelligence models to accelerate both hit identification and chemical diversification in the field of allostery, according to Excelra.